HGHSX Hartford Healthcare R4 Forecast, Technical & Fundamental Analysis

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Unitedhealth Group (NYSE:UNH), Merck & Co (NYSE:MRK), ABBVIE (NYSE:ABBV), Boston Scientific Corp (NYSE:BSX).

The investment seeks long-term capital appreciation. Under normal circumstances, the fund invests at least 80% of its assets in the equity securities of health care-related companies worldwide as selected by the sub-adviser, Wellington Management Company LLP ("Wellington Management"). The fund takes a broad approach to investing in the health care sector. It may invest in health-related companies, including companies in the pharmaceuticals, biotechnology, medical delivery, medical products, medical services, managed health care, health information services and emerging health-related subsectors.

The average market capitalization across the Hartford Healthcare R4 MF is 269.82B. The market cap for tickers in the group ranges from 88.21B to 739.66B. LLY holds the highest valuation in this group at 739.66B. The lowest valued company is HCA at 88.21B.

The average weekly volume growth across all stocks in the Hartford Healthcare R4 MF was -45%. For the same stocks of the MF, the average monthly volume growth was 25% and the average quarterly volume growth was 53%